Funds holding Eagle Pharmaceuticals Inc/DE
ISIN US2697961082 · United States · LEI 549300TN20OLYTJVP152
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 787.9 $
A single tracked fund declares this company: these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Diversified Equity Master Portfolio Master Investment Portfolio | 2,310 | 787.9 $ | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | -1 | 2,310 | -55.5 % |
| 2026Q1 | 2 | 0 | 5,188 | 0.0 % |
| 2025Q4 | 2 | 0 | 5,188 | -2.1 % |
| 2025Q3 | 2 | -1 | 5,300 | -89.2 % |
| 2025Q2 | 3 | -3 | 48,880 | -40.8 % |
| 2025Q1 | 6 | -16 | 82,603 | -91.2 % |
| 2024Q4 | 22 | -57 | 933,498 | -50.1 % |
| 2024Q3 | 79 | -45 | 1,871,094 | -12.8 % |
| 2024Q2 | 124 | -30 | 2,146,249 | -30.8 % |
| 2024Q1 | 154 | -22 | 3,101,165 | -13.8 % |
| 2023Q4 | 176 | 3,599,671 |
Institutional managers
2 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Stanley-Laman Group, Ltd. | 12,000 | 4.1K $ | as of Mar 31, 2026 |
| Archer Investment Corp | 350 | 119 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Eagle Pharmaceuticals Inc/DE". https://titelia.com/en/stocks/eagle-pharmaceuticals-inc-de-US2697961082